CAS 909-39-7|OPIPRAMOL DIHYDROCHLORIDE

Introduction:Basic information about CAS 909-39-7|OPIPRAMOL DIHYDROCHLORIDE, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameOPIPRAMOL DIHYDROCHLORIDE
CAS Number909-39-7Molecular Weight436.41800
Density/Boiling Point/
Molecular FormulaC23H31Cl2N3OMelting Point/
MSDSChineseUSAFlash Point/
Symbol
GHS07, GHS09
Signal WordWarning

Names

Name2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol,dihydrochloride
SynonymMore Synonyms

Chemical & Physical Properties

Molecular FormulaC23H31Cl2N3O
Molecular Weight436.41800
Exact Mass435.18400
PSA29.95000
LogP4.85330
InChIKeyDLTOEESOSYKJBK-UHFFFAOYSA-N
SMILESCl.Cl.OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TL9100000
CHEMICAL NAME :
1-Piperazineethanol, 4-(3-(5H-dibenz(b,f)azepin-5-yl)propyl)-, dihydrochloride
CAS REGISTRY NUMBER :
909-39-7
LAST UPDATED :
199606
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C23-H29-N3-O.2Cl-H
MOLECULAR WEIGHT :
436.47
WISWESSER LINE NOTATION :
T C676 BNJ B3- AT6N DNTJ D2Q &GH 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human
DOSE/DURATION :
36 mg/kg/25D-C
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
AJPSAO American Journal of Psychiatry. (American Psychiatric Assoc., Circulation Dept., 1400 K St., NW, Washington, DC 20005) V.78- 1921- Volume(issue)/page/year: 119,465,1962
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
900 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,161,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
95 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 148,560,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
497 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 148,560,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
32 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 148,560,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
443 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
RSPSA2 Rassegna di Studi Psichiatrici. Review of Psychiatric Studies. (Ospedale Psichiatrico, 53100 Siena, Italy) V.1- 1911- Volume(issue)/page/year: 52,204,1963
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
120 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 148,560,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
315 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 148,560,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
45 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 148,560,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
11 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 148,560,1964

Safety Information

Symbol
GHS07, GHS09
Signal WordWarning
Hazard StatementsH302-H410
Precautionary StatementsP273-P501
Risk Phrases22-50/53
Safety Phrases60-61
RIDADRUN 3077 9 / PGIII
RTECSTL9100000

Articles25

More Articles
Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression.

World J. Biol. Psychiatry 7(4) , 261-4, (2006)

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive experimental technique which has mostly been investigated in the treatment of mood disorders with possible efficacy in depression....

In vitro studies of DNA damage caused by tricyclic antidepressants: a role of peroxidase in the side effects of the drugs.

Chem. Res. Toxicol. 23(9) , 1497-503, (2010)

Studies show that tricyclic antidepressants prescribed for migraines, anxiety, and child enuresis have numerous adverse effects in living cells. One of the undesired outcomes observed under treatment ...

Opipramol improves subjective quality of sleep the night prior to surgery: confirmatory testing of a double-blind, randomized clinical trial.

Neuropsychobiology 64(1) , 24-31, (2011)

Due to its pharmacological properties, opipramol may be useful in the context of evening premedication in anaesthesiology. This trial examines whether quality of sleep the night prior to surgery can b...

Synonyms

4-[3-(5H-dibenz[b,f]azepin-5-yl)propyl]-1-piperazineethanol,dihydrochloride
Pramolan
Opipramol-dihydrochlorid
Insidon
UNII-B49OBI656M
Opipramol dihydrochloride
Opipramol hydrochloride
EINECS 213-000-2
Opipramol hydrochloride [USAN]
Ensidon
Opipramol HCl
CAS 1376933-60-6|1-((4-(Tert-butyldimethylsilyloxy)chroman-8-yl)methyl)piperidine
CAS 291289-76-4|1,3-Dimethylindole-7-carboxylic acid
Recommended......
TOP